APR 03, 2018 7:54 PM PDT

Beneficial Genetic Mutations Could Help Patients

WRITTEN BY: Carmen Leitch

New research findings could help develop treatments for a variety of blood disorders, like sickle cell anemia. CRISPR gene editing was used in a study led by UNSW Sydney, in which beneficial mutations were introduced to blood cells, increasing the production of a molecule called fetal hemoglobin. These 'good' mutations are naturally carried by some people, and this work solves long-standing questions about how they impact gene expression. It was reported in Nature Genetics.

A sickle cell / Credit: Pixnio

"Our new approach can be seen as a forerunner to 'organic gene therapy' for a range of common inherited blood disorders including beta-thalassemia and sickle cell anemia," said study leader Professor Merlin Crossley, Deputy Vice-Chancellor Academic of UNSW. "It is organic because no new DNA is introduced into the cells; rather we engineer in naturally occurring, benign mutations that are known to be beneficial to people with these conditions. It should prove to be a safe and effective therapy, although more research would be needed to scale the processes up into effective treatments."

In the sickle cell anemia and thalassemia disorders, patients have a problem with their hemoglobin molecule, which has a critical role in our bodies. It gathers oxygen up from the lungs and moves it through the blood to other areas. Those with such blood diseases need transfusions and medications their entire lives. However, some also have mutations in their genome that offset the disease, mutations that activate fetal hemoglobin and compensate for the loss of their adult hemoglobin molecule.

"The fetal hemoglobin gene is naturally silenced after birth. For 50 years, researchers have been competing furiously to find out how it is switched off, so it can be turned back on," said Crossley. "Our study, which is the culmination of many years of work, solves that mystery.”

The researchers identified the mechanism underlying the rescue. “We have found that two genes, called BCL11A and ZBTB7A, switch off the fetal hemoglobin gene by binding directly to it. And the beneficial mutations work by disrupting the two sites where these two genes bind,” continued Crossley.

"This landmark finding not only contributes to our appreciation of how these globin genes are regulated. It means we can now shift our focus to developing therapies for these genetic diseases using CRISPR to target precise changes in the genome," added Crossley.

The most common genetic disorders in the world that affect one gene are beta-thalassemia and sickle cell anemia. The globin genes have also been well-characterized. Now this work can bring the knowledge about the gene to benefit patients.

 

Sources: AAAS/Eurekalert! Via UNSW, Nature Genetics

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 31, 2019
Genetics & Genomics
DEC 31, 2019
Using Machine Learning to Analyze Gene Regulation
Computational tools are becoming increasingly important in biological research. Now scientists have found a way to use machine learning in a way that will make sense to biologists....
JAN 09, 2020
Neuroscience
JAN 09, 2020
Why Do you Have a Higher IQ than your Grandparents?
In the 1980’s James Flynn found that on average, human intelligence quotients (IQ) increase by 3 points every 10 years. Known as the “Flynn eff...
FEB 03, 2020
Cell & Molecular Biology
FEB 03, 2020
Brain Organoids May Not be Living Up to the Hype
Cells can be grown in special ways to create three-dimensional, miniature models of organs. But how good are they?...
FEB 03, 2020
Neuroscience
FEB 03, 2020
Genetic Characterization of Bipolar Disorders, Major Depressive Disorder
Mood disorders, like Bipolar, Major Depressive Disorder, and Schizophrenia, among others, are difficult to define clinically.  Unlike disorders that a...
FEB 26, 2020
Genetics & Genomics
FEB 26, 2020
Optogenetic Techniques Provide Insight Into ALS
In humans, motor neurons link thoughts with the motion of the body. Now researchers have learned more about how they are impacted by ALS....
MAR 16, 2020
Genetics & Genomics
MAR 16, 2020
How To: Recombinant Protein Construct Design
Creating recombinant proteins has become much easier over the past few decades. However, those with the skills to do design such constructs are usually lim...
Loading Comments...